Close Menu

Irony at the NIH

Mike the Mad Biologist is a bit taken aback as he points to a statistical analysis in PLoS One that shows the NIH peer review process is not exactly steeped in the principles of statistical sampling. The paper says that the current number of recommended reviewers for each grant doesn't provide the level of precision that the NIH mandates for scoring the application.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.

NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.

In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.